| Flucloxacillin 250 mg Capsules PA1418/016/001 |
Flucloxacillin |
Athlone Pharmaceuticals Limited |
Marketed |
| Flucloxacillin 250mg/5ml Oral Solution PA1418/016/004 |
Flucloxacillin |
Athlone Pharmaceuticals Limited |
Marketed |
| Flucloxacillin 500 mg capsules PA1418/016/002 |
Flucloxacillin |
Athlone Pharmaceuticals Limited |
Marketed |
| Flucloxacillin 500 mg film-coated tablets PA22871/026/001 |
FLUCLOXACILLIN SODIUM |
Azure Pharmaceuticals Ltd. |
Marketed |
| Flucloxacillin 500 mg powder for solution for injection/infusion PA2059/069/001 |
FLUCLOXACILLIN SODIUM |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Fludrocortisone Acetate Renata 0.1 mg tablets PA22865/007/001 |
Fludrocortisone acetate |
Renata Pharmaceuticals (Ireland) Limited |
Not marketed |
| Fluenz nasal spray suspension Influenza vaccine (live, nasal) EU/1/24/1816/001-002 |
REASSORTANT INFLUENZA VIRUS (LIVE ATTENUATED) B/<OFFICIAL STRAIN> LIKE STRAIN (<ACTUAL STRAIN>) 10^7.0±0.5 FLUORESCENT FOCUS UNITS PER 0.2 ML, REASSORTANT INFLUENZA VIRUS (LIVE ATTENUATED) A/<OFFICIAL STRAIN> (H3N2) LIKE STRAIN (<ACTUAL STRAIN>) 10^7.0±0.5 FLUORESCENT FOCUS UNITS PER 0.2 ML, REASSORTANT INFLUENZA VIRUS (LIVE ATTENUATED) A/<OFFICIAL STRAIN> (H1N1) LIKE STRAIN (<ACTUAL STRAIN>) 10^7.0±0.5 FLUORESCENT FOCUS UNITS PER 0.2 ML |
AstraZeneca AB |
— |
| Fluoxetine 10 mg hard capsule PA1567/007/001 |
FLUOXETINE HYDROCHLORIDE |
Activase Pharmaceuticals Limited |
Not marketed |
| Fluoxetine 20 mg hard capsule PA1567/007/002 |
FLUOXETINE HYDROCHLORIDE |
Activase Pharmaceuticals Limited |
Not marketed |
| Fluoxetine 30 mg hard capsule PA1567/007/003 |
FLUOXETINE HYDROCHLORIDE |
Activase Pharmaceuticals Limited |
Not marketed |
| Fluoxetine 40 mg hard capsule PA1567/007/004 |
FLUOXETINE HYDROCHLORIDE |
Activase Pharmaceuticals Limited |
Not marketed |
| Fluoxetine 60 mg hard capsule PA1567/007/005 |
FLUOXETINE HYDROCHLORIDE |
Activase Pharmaceuticals Limited |
Not marketed |
| Flutiform 125 microgram/5 microgram per metered dose pressurised inhalation, suspension PA1688/013/002 |
Fluticasone propionate, Formoterol fumarate dihydrate |
Mundipharma Pharmaceuticals Limited |
Marketed |
| Flutiform 250 microgram/10 microgram per metered dose pressurised inhalation, suspension PA1688/013/003 |
Fluticasone propionate, Formoterol fumarate dihydrate |
Mundipharma Pharmaceuticals Limited |
Marketed |
| Flutiform 50 microgram/5 microgram per metered dose pressurised inhalation, suspension PA1688/013/001 |
Fluticasone propionate, Formoterol fumarate dihydrate |
Mundipharma Pharmaceuticals Limited |
Marketed |
| Foclivia EU/1/09/577/1-4 |
A/vietnam/1194/2004 (h5n1) virus surface inactivated antigen |
Seqirus S.r.l. |
— |
| Folinic acid (as calcium folinate) 10 mg/ml solution for injection or infusion PA2059/001/001 |
Folinic acid |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Forsteo 20 micrograms/80 microliters solution for injection in pre-filled pen EU/1/03/247/01-2 |
Teriparatide |
Eli Lilly Nederland B.V. |
— |
| Fortacin 150 mg/ml + 50 mg/ml cutaneous spray, solution EU/1/13/381/001 |
Lidocaine, Prilocaine |
Recordati Ireland Limited |
— |
| Fortum 1 g powder for solution for injection or infusion PA23311/001/002 |
Ceftazidime |
Sandoz Pharmaceuticals d.d. |
Marketed |
| Fortum 2 g powder for solution for injection or infusion PA23311/001/003 |
Ceftazidime |
Sandoz Pharmaceuticals d.d. |
Marketed |
| Fortum 500 mg powder for solution for injection PA23311/001/001 |
Ceftazidime |
Sandoz Pharmaceuticals d.d. |
Marketed |
| Forxiga 10 mg film-coated tablets EU/1/12/795/006-010 |
Dapagliflozin propanediol monohydrate equivalent to 10mg dapagliflozin |
AstraZeneca AB |
— |
| Forxiga 5 mg film-coated tablets EU/1/12/795/001-005 |
Dapagliflozin propanediol monohydrate equivalent to 5mg dapagliflozin |
AstraZeneca AB |
— |
| Fosavance 70 mg/2800 IU tablets EU/1/05/310/1-4 |
Vitamin d3, Alendronic acid |
N.V. Organon |
— |
| Fosavance 70 mg/5600 IU tablets EU/1/05/310/6-8 |
Vitamin d3, Alendronic acid |
N.V. Organon |
— |
| Fostair 100 microgram/6 microgram per actuation pressurised inhalation solution PA0584/008/001 |
Beclometasone dipropionate, Formoterol fumarate dihydrate |
Chiesi Farmaceutici S.p.A. |
Not marketed |
| Fostair 200 microgram/6 microgram per actuation pressurised inhalation solution PA0584/008/003 |
Beclometasone dipropionate, Formoterol fumarate dihydrate |
Chiesi Farmaceutici S.p.A. |
Not marketed |
| Fostair Nexthaler 100 micrograms/6 micrograms per metered dose inhalation powder PA0584/008/002 |
Beclometasone dipropionate, Formoterol fumarate dihydrate |
Chiesi Farmaceutici S.p.A. |
Not marketed |
| Fostair Nexthaler 200 micrograms/6 micrograms per metered dose inhalation powder PA0584/008/004 |
Formoterol fumarate dihydrate, Beclometasone dipropionate anhydrous |
Chiesi Farmaceutici S.p.A. |
Not marketed |
| Fostimon 150 IU, powder and solvent for solution for injection PA1104/002/002 |
Urofollitropin |
IBSA Farmaceutici Italia S.r.l |
Not marketed |
| Fostimon 75 IU, powder and solvent for solution for injection PA1104/002/001 |
Urofollitropin |
IBSA Farmaceutici Italia S.r.l |
Not marketed |
| Fostimon PFS 150 IU Powder and Solvent for Solution for Injection PA1104/002/004 |
Urofollitropin |
IBSA Farmaceutici Italia S.r.l |
Not marketed |
| Fostimon PFS 225 IU Powder and Solvent for Solution for Injection PA1104/002/005 |
Urofollitropin |
IBSA Farmaceutici Italia S.r.l |
Not marketed |
| Fostimon PFS 300 IU Powder and Solvent for Solution for Injection PA1104/002/006 |
Urofollitropin |
IBSA Farmaceutici Italia S.r.l |
Not marketed |
| Fostimon PFS 75 IU Powder and Solvent for Solution for Injection PA1104/002/003 |
Urofollitropin |
IBSA Farmaceutici Italia S.r.l |
Not marketed |
| Fotivda 1340 microgram hard capsules EU/1/17/1215/002 |
Tivozanib |
EUSA Pharma (Netherlands) B.V. |
— |
| Fotivda 890 microgram hard capsules EU/1/17/1215/001 |
Tivozanib |
EUSA Pharma (Netherlands) B.V. |
— |
| Foznol 1000 mg Chewable Tablets PA23211/002/004 |
Lanthanum |
Takeda Pharmaceuticals International AG Ireland Branch |
Marketed |
| Foznol 1000 mg Oral Powder PA23211/002/006 |
Lanthanum carbonate hydrate |
Takeda Pharmaceuticals International AG Ireland Branch |
Not marketed |
| Foznol 250 mg Chewable Tablets PA23211/002/001 |
Lanthanum carbonate hydrate |
Takeda Pharmaceuticals International AG Ireland Branch |
Not marketed |
| Foznol 500 mg Chewable Tablets PA23211/002/002 |
Lanthanum |
Takeda Pharmaceuticals International AG Ireland Branch |
Marketed |
| Foznol 750 mg Chewable Tablets PA23211/002/003 |
Lanthanum |
Takeda Pharmaceuticals International AG Ireland Branch |
Marketed |
| Foznol 750 mg Oral Powder PA23211/002/005 |
Lanthanum carbonate hydrate |
Takeda Pharmaceuticals International AG Ireland Branch |
Not marketed |
| FRUZAQLA 1 mg hard capsules EU/1/24/1827/001 |
Fruquintinib |
Hutchmed Europe B.V. |
— |
| FRUZAQLA 5 mg hard capsules EU/1/24/1827/002 |
Fruquintinib |
Hutchmed Europe B.V. |
— |
| Fulphila 6 mg solution for injection in pre-filled syringe EU/1/18/1329/001-002 |
Pegfilgrastim |
Biosimilar Collaborations Ireland Limited |
— |
| Fulvestrant Mylan 250 mg solution for injection in pre-filled syringe EU/1/17/1253/001-002 |
Fulvestrant |
Mylan Pharmaceuticals Limited |
— |
| Furosemide 20 mg/2 ml solution for injection/infusion PA2059/038/001 |
Furosemide |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Furosemide 20mg in 2ml Solution for Injection PA0073/059/004 |
Furosemide |
Mercury Pharmaceuticals (Ireland) Ltd |
Marketed |